MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology _ Pancreas, Pancreatic
Actuate Therapeutics, Inc. (NASDAQ: ACTU)*
Organization & Developments: Actuate Therapeutics
Parents
Actuate Therapeutics, Inc. (NASDAQ: ACTU)*
Children
*Clinical stage biopharmaceutical developing treatments for cancers through the inhibition of glycogen synthase kinase-3 (GSK-3).
*Developing elraglusib (formerly 9-ING-41), a small molecule designed to enter cancer cells and block the function of the enzyme GSK-3β, a master regulator of complex biological signaling cascades
2026: Two New Drugs Offer Hope for Pancreatic Cancer
Jumps
Finance & Acquisition: Actuate Therapeutics
Key People: Actuate Therapeutics